B+
Bull case
30%
Probability
Target price
$60.00
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
AHR
American Healthcare REITCNYSE / Equity Real Estate Investment Trusts (REITs)
Last Price
Quote time unavailable
Current thesis
The best post-earnings read is that AHR combined strong same-store NOI growth with a guide raise, lower leverage, and visible liquidity, which supports a case for further rerating if the SHOP and ISHC growth engine stays intact.
Posture
Mixed
Lead driver
Value
What changed
5 setup hits (3d) with net bullish as of 2026-10-26.
What can break
A checked secondary earnings summary indicated revenue came in below consensus even as FFO beat, which raises the bar for sustained NOI and acquisition execution to support the current multiple.
Momentum
61
Value
49
Sentiment
51
Setup hits (3d)
5 · Net Bullish
AI TargetsBase $55.00 · Bull $60.00 · Bear $44.00Analysis 2026-05-09; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-26
Investment thesis
As of 2026-10-26
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $63.69
Why
Momentum61 · Δ7d +1.9
Value49 · Δ7d -
Sentiment51 · Δ7d +0.6
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Confirming evidence
- • 5 setup hits (3d) with net bullish as of 2026-10-26.
- • Value remains the lead driver in the composite.
Contradictions & invalidation
- • A checked secondary earnings summary indicated revenue came in below consensus even as FFO beat, which raises the bar for sustained NOI and acquisition execution to support the current multiple.
- • AHR disclosed in a February 4, 2026 IR release that CEO Danny Prosky took medical leave and Jeffrey Hanson became interim CEO and president [#IR-2026-02-04], leaving a governance/continuity watch item.
- • The more cautious read is that external growth still depends on settling a large forward-equity stack and closing pipeline deals that are not yet included in guidance; checked sources did not surface clear post-print analyst target revisions by 2026-05-09, so the upgrade signal is incomplete.
Catalyst clock
2026-05-07
Q1 print beat on NFFO and management raised 2026 operating guidance
Lead driver: Value · See fundamentals
Momentum
61
8% active weight
Current posture
7d trendFlat
Δ7d
+1.9
Δ21d
+13.3
Value
49
47% active weight
Current posture
7d trendFlat
Δ7d
-
Δ21d
-
Sentiment
51
45% active weight
Current posture
7d trendFlat
Δ7d
+0.6
Δ21d
-12.7
Why this grade
Composite grade C. Momentum 60.8 / Value 48.9 / Sentiment 51.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-05-09. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$55.00
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$44.00
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-26
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$11.76B
Beta
-
Shares Out
217.61M
P/E (TTM)
331.3
P/S (TTM)
3.98
P/FCF (TTM) · Derived
562.78
Rev YoY
+24.3%
EPS YoY
+157.4%
Gross Margin
+9.5%
Op Margin
+6.8%
Net Debt
$1.5B
Current Ratio
1.19
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data